AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Clinical trials for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA trials appear
Sign up with your email to follow new studies for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for calming Alzheimer's agitation
Symptom relief Recruiting nowThis study is testing whether an experimental drug called ONO-2020 can safely reduce agitation in people with Alzheimer's disease. It will involve about 90 patients in Japan who will be randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to se…
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co. Ltd • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
New hope for calming Alzheimer's agitation
Symptom relief Recruiting nowThis study is testing two new drugs, EXV-802 and EXV-801, to see if they can safely reduce agitation in people with Alzheimer's dementia. About 300 participants, aged 55-90, will be randomly assigned to receive one of the drugs or a placebo for 6 weeks. The main goal is to see if…
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2, PHASE3 • Sponsor: Exciva GmbH • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC